ATE164230T1 - 4verfahren und zusammensetzungen zur vorbeugung, diagnose und behandlung seröser entzündungen und damit verbundener störungen - Google Patents

4verfahren und zusammensetzungen zur vorbeugung, diagnose und behandlung seröser entzündungen und damit verbundener störungen

Info

Publication number
ATE164230T1
ATE164230T1 AT92911960T AT92911960T ATE164230T1 AT E164230 T1 ATE164230 T1 AT E164230T1 AT 92911960 T AT92911960 T AT 92911960T AT 92911960 T AT92911960 T AT 92911960T AT E164230 T1 ATE164230 T1 AT E164230T1
Authority
AT
Austria
Prior art keywords
constituents
lamellar bodies
disclosed
compositions
disease
Prior art date
Application number
AT92911960T
Other languages
English (en)
Inventor
James W Dobbie
Original Assignee
Baxter Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Int filed Critical Baxter Int
Application granted granted Critical
Publication of ATE164230T1 publication Critical patent/ATE164230T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT92911960T 1991-05-29 1992-05-29 4verfahren und zusammensetzungen zur vorbeugung, diagnose und behandlung seröser entzündungen und damit verbundener störungen ATE164230T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US70569991A 1991-05-29 1991-05-29

Publications (1)

Publication Number Publication Date
ATE164230T1 true ATE164230T1 (de) 1998-04-15

Family

ID=24834572

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92911960T ATE164230T1 (de) 1991-05-29 1992-05-29 4verfahren und zusammensetzungen zur vorbeugung, diagnose und behandlung seröser entzündungen und damit verbundener störungen

Country Status (5)

Country Link
EP (1) EP0544862B1 (de)
AT (1) ATE164230T1 (de)
AU (1) AU665764B2 (de)
DE (1) DE69224795T2 (de)
WO (1) WO1992021981A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5747474A (en) * 1996-07-29 1998-05-05 Immune Modulation, Inc. Immunosuppression by administration of N6,N6 -disubstituted cAMP's, analogues thereof, and related nucleosides
GB0007150D0 (en) * 2000-03-24 2000-05-17 Lamellar Therapeutics Limited Immunotherapeutic methods and compositions
US7462618B2 (en) * 2003-08-27 2008-12-09 Sun Health Research Institute Treatment of inflammatory autoimmune diseases with alpha-adrenergic antagonists and beta-adrenergic agonists
GB0322448D0 (en) 2003-09-25 2003-10-29 Lamellar Therapeutics Ltd Using lamellar bodies to modify linear biological macro molecules
EP1667693B1 (de) * 2003-09-25 2015-06-24 Lamellar Biomedical Limited Zusammensetzungen und verfahren unter verwendung von lamellenkörpern für therapeutische zwecke

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5403592A (en) * 1987-08-25 1995-04-04 Macnaught Pty Limited Lubricant composition for rheumatism
AU620821B2 (en) * 1987-08-25 1992-02-27 Macnaught Pty Limited Hyaluronic acid lubricating compounds
CA2005190A1 (en) * 1988-12-12 1990-06-12 Morgan Van Aken Detection of basement membrane components as diagnostic of cancer and other diseases
EP0450099B1 (de) * 1989-10-19 1996-09-11 Yamasa Shoyu Kabushiki Kaisha Träger zur bindung von antiphospholipid-antikörpern, diese antikörper verwendender immunotest und kit dafür

Also Published As

Publication number Publication date
EP0544862A1 (de) 1993-06-09
AU2011892A (en) 1993-01-08
EP0544862B1 (de) 1998-03-18
WO1992021981A1 (en) 1992-12-10
DE69224795T2 (de) 1998-11-19
DE69224795D1 (de) 1998-04-23
AU665764B2 (en) 1996-01-18

Similar Documents

Publication Publication Date Title
Forni et al. Radiofrequency destruction of the tuberoinfundibular region of hypothalamus permanently abrogates NK cell activity in mice
Lance et al. A physiological approach to clinical neurology
Mattson et al. Isoelectric focusing of IgG eluted from multiple sclerosis and subacute sclerosing panencephalitis brains
DE69830185D1 (de) Verfahren zur unterstützung der differentialdiagnostik und behandlung von autistischen syndromen
BR0011000A (pt) Métodos para prevenir ou tratar uma doença associada com depósitos amilóides de ab no cérebro de um paciente, para avaliar um anticorpo quanto á atividade de remoção de uma entidade biológica fisicamente associada com um antìgeno e para detectara um depósito amilóide em um paciente, composição farmacêutica, e, conjunto de diagnóstico
ATE330631T1 (de) Antikörperfragmente zur lokalen behandlung von augenerkrankungen
PT912898E (pt) Metodo imunologico de deteccao de anticorpos dirigidos contra a transglutaminase (ttg) utilizacao de ttg para o diagnostico e controlo de terapia assim como agente farmaceutico oral contendo ttg
DE69028712D1 (de) Zusammensetzung zur behandlung entzündlicher darmerkrankungen
EP0600930A4 (de) Diagnose und behandlung von autoimmunkrankheiten.
Shavit-Stein et al. Blocking thrombin significantly ameliorates experimental autoimmune neuritis
WO2003040183A3 (en) Compounds for the diagnosis/prevention/treatment of alzheimer's disease
Garcia-Monco et al. Mechanisms of injury in Lyme neuroborreliosis
Andermann et al. Observations on hypertrophic neuropathy of Dejerine and Sottas
ATE164230T1 (de) 4verfahren und zusammensetzungen zur vorbeugung, diagnose und behandlung seröser entzündungen und damit verbundener störungen
Yokota et al. Persistent increased threshold of electrical stimulation selective to motor nerve in multifocal motor neuropathy
AU2579995A (en) Alpha b crystallin for use in diagnosis and therapy of auto-immune diseases in particular multiple sclerosis
Serup et al. Bone mineral content in systemic sclerosis measured by photonabsorptiometry
Pelc et al. The structure and function of the epidermal barrier in patients with atopic dermatitis–treatment options. Part two
Patrick FACIAL DIPLEGIA IN MULTIPLE NEURITIS1
DE60127935T2 (de) Verfahren zur diagnose der effektivität der xenotypischen antikörpertherapie
RU2124879C1 (ru) Способ комплексной рефлексотерапии
McDonald et al. Focal upper limb neuropathy in a child
Konkol et al. Schilder's disease: additional aspects and a therapeutic option
Dogheim et al. Serum immunoglobulin levels in rhinoscleroma contacts
Chin A case of bilateral ulnar nerve palsy in a patient with traumatic brain injury and heterotopic ossification

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties